KV Pharmaceutical Company Completes Unaudited Fiscal 2007 Results; Receives Trading Extension...(sets and goodwill net ...),Health

Other assets 20,403 19,026

Total Assets $707,783 $619,313

LIABILITIES

Current Liabilities:

Accounts payable $18,506 $17,975

Accrued liabilities 38,776 24,676

Current maturities of long-term debt 1,897 1,681

Total Current Liabilities 59,179 44,332

Long-term debt 239,451 241,319

Other long-term liabilities 6,319 5,442

Deferred tax liability 38,007 25,221

Total Liabilities 342,956 316,314

Commitments and Contingencies

SHAREHOLDERS' EQUITY

7% cumulative convertible Preferred Stock,

$.01 par value; $25.00 stated and liquidation

value; 840,000 shares authorized; issued and

outstanding - 40,000 shares at both March 31,

2007 and 2006 (convertible into Class A shares

at a ratio of 8.4375-to-one) - -

Class A and Class B Common Stock, $.01 par value;

150,000,000 and 75,000,000 shares authorized,

respectively;

Class A - issued 40,316,426 and 39,660,637 at

March 31, 2007 and 2006, respectively 403 397

Class B - issued 12,393,982 and 12,679,986 at

March 31, 2007 and 2006, respectively

(convertible into Class A shares on a

one-for-one basis) 124 127

Additional paid-in capital 150,818 145,180

Retained earnings 269,430 211,410

Acc
'/>"/>